CD274 and neoplasm: Interestingly, in the PD-L1 tumor proportion score (TPS) ≥50% subgroup, the DFS difference did not reach statistical significance (HR 0.82; 95% CI 0.57–1.18; p = 0.14), highlighting potential variability in predictive biomarker performance across different ICIs.